Accepted Manuscript Probiotic features of Lactobacillus strains isolated from Ragusano and Pecorino Siciliano cheeses C. Caggia, M. De Angelis, I. Pitino, A. Pino, C.L. Randazzo PII:
S0740-0020(15)00071-4
DOI:
10.1016/j.fm.2015.03.010
Reference:
YFMIC 2375
To appear in:
Food Microbiology
Received Date: 3 December 2014 Revised Date:
4 March 2015
Accepted Date: 26 March 2015
Please cite this article as: Caggia, C., De Angelis, M., Pitino, I., Pino, A., Randazzo, C.L., Probiotic features of Lactobacillus strains isolated from Ragusano and Pecorino Siciliano cheeses, Food Microbiology (2015), doi: 10.1016/j.fm.2015.03.010. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT 1
Probiotic features of Lactobacillus strains isolated from Ragusano and Pecorino Siciliano
2
cheeses
3 4
C. Caggiaa, M. De Angelisb, I. Pitinoa, A. Pinoa, C.L. Randazzoa*
5
a
6
b
RI PT
Department of Agriculture, Food and Environment, University of Catania, Catania, Italy Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Bari, Italy
7
SC
8 9
Keywords: lactobacilli; traditional cheese; resistance to low pH; tolerance to bile salts; adhesion
11
ability; transit to GI tract
M AN U
10
12 Abstract
14
In the present study 177 Lactobacillus spp. strains, isolated from Ragusano and Pecorino Siciliano
15
cheeses, were in vitro screened for probiotic traits, and their characteristics were compared to those
16
of Lactobacillus rhamnosus GG, commercial strain. Based on acidic and bile salt resistance,
17
thirteen Lactobacillus strains were selected. The multiplex-PCR application revealed that nine
18
strains belonged to Lactobacillus rhamnosus species and four to Lactobacillus paracasei species.
19
All selected strains were further investigated for transit tolerance in simulated upper gastrointestinal
20
tract (GI), for adhesion capacity to human intestinal cell lines, for hydrophobicity, for co-
21
aggregation and auto-aggregation and for antimicrobial activities. Moreover, antibiotic resistance,
22
haemolytic and bile salt hydrolase activities were investigated for safety assessment.
AC C
EP
TE D
13
23 24 25
*corresponding author: Tel: +39 095 7580218; fax: +39 095 7141960.
26
E-mail address:
[email protected] (C.L. Randazzo) 1
ACCEPTED MANUSCRIPT Viable counts after simulated gastric and duodenal transit revealed that overall the selected
28
lactobacilli tolerated better pancreatic juice and bile salts than acidic juice. In particular, three L.
29
rhamnosus strains (FS10, FS2, and PS11) and one L. paracasei strain (PM8) increased their cell
30
density after the simulated GI transit. The same strains showed also high percentage of auto-
31
aggregation and co-aggregation with Escherichia coli. All strains were effective against both
32
Staphylococcus aureus and E. coli and variability was achieved versus Listeria monocytogenes and
33
Enterococcus faecalis used as pathogenic indicator strains.
34
Different behavior was revealed by strains for adhesion ability and hydrophobicity, which are not
35
always linked each other and are strongly strain-dependent. From the safety point of view, no
36
isolate showed hemolytic and bile salt hydrolase activities, except one, and most of the strains were
37
sensitive to a broad range of clinical antibiotics.
38
This work showed that the L. rhamnosus FS10 and the L. paracasei PM8 are good promising
39
probiotic candidates for further in vivo investigations.
M AN U
SC
RI PT
27
TE D
40
Keywords: probiotics; simulated GI transit tolerance; safety assessment; acidic and bile resistances;
42
antibiotic resistance; principal component analysis.
43
EP
41
1. Introduction
45
Probiotics are defined as “live microorganisms which, when administered in adequate amounts,
46
confer a health benefit on the host” (FAO/WHO, 2002). Probiotics may beneficially affect the host
47
by modulating immune responses, influencing its metabolic activities (e.g. cholesterol assimilation)
48
and performing useful metabolic activities (e.g., lactase activity, vitamin production, antimicrobial
49
activity).
50
The most studied probiotics belong to Lactobacillus and Bifidobacterium genera and, among them,
51
Lactobacillus species are commensal and non-pathogenic inhabitants of human and animal
52
intestine, of oral cavity and vagina (Walter 2008; Chen et al., 2010) and have been considered as
AC C
44
2
ACCEPTED MANUSCRIPT valuable probiotic organisms since they contribute to the inhibition of harmful intestinal bacteria
54
(Walter 2008; van Baarlen et al., 2013). Lactobacilli are food-grade organisms witnessing a long
55
history of safe use being widely consumed with fermented foods and beverages (Salminen et al.,
56
1998; Leroy and De Vuyst, 2004; Bernardeau et al., 2008). Most of them received the Qualified
57
Presumption of Safety (QPS) status (EFSA, 2012). Lactobacilli display a naturally wide range of
58
antibiotic resistance and in most cases it is not of the transmissible type (Charteris et al., 1998).
59
Lactobacilli possess inhibitory properties against enteropathogens thanks to production of several
60
antimicrobial compounds (Collado et al., 2007). The latter is a key criterion which should be taken
61
into account for selection of probiotic strains since it is considered an important ecological factor
62
determining the dominant bacteria in the intestinal ecosystem. Nevertheless, characteristics ascribed
63
to probiotics are strain specific and should be individually tested. For selection of a promising
64
probiotic strain, several aspects of functionality should be considered and the first tool is
65
represented by in vitro methods aiming to ascertain the ability to survive through the upper GI
66
(Saarela et al., 2000). Tolerance to gastric juice and bile salts become a crucial factor for selection
67
of new probiotic strains as well as the ability to adhere to epithelial surfaces and to persist in the
68
human GI-tract. The testing of their in vivo efficacy is expensive and time-consuming. For this
69
reason, reliable in vitro methods are required for selecting new strains of probiotic bacteria to obtain
70
profitable in vivo effects.
71
Together with the GI tract, dairy products are considered the main sources for isolation of novel
72
promising probiotic organisms (Ambadoyiannis et al., 2005) and several studies have demonstrated
73
their potentiality as good vehicle for probiotics delivery to human (Bergamini et al., 2010; Oberg et
74
al., 2011; Pitino et al., 2012). In particular, traditional dairy products, such as cheeses, represent a
75
plentiful source of lactobacilli. Among traditional cheeses, Ragusano and Pecorino types are
76
Protected Denomination of Origin (PDO) cheeses made in Sicily from raw milk through a
77
traditional cheese-making process, without addition of commercial starter cultures. During the
78
manufacture and the cheese ripening, the microbiota naturally evolves, increasing the diversity of
AC C
EP
TE D
M AN U
SC
RI PT
53
3
ACCEPTED MANUSCRIPT Lactobacillus species (Randazzo et al., 2002; 2006; Licitra et al., 2007), with potential probiotic
80
functions.
81
Therefore, the aims of the present study were (i) to establish in vitro the functional and safety
82
characteristics of potential probiotic Lactobacillus strains, isolated from Ragusano and Pecorino
83
Siciliano cheeses; (ii) to compare their features to those of commercial Lactobacillus rhamnosus
84
ATCC 53103 (strain GG); and (iii) to identify the promising strains throughout genotypic methods.
RI PT
79
85
87
SC
86 2. Material and methods
M AN U
88
2.1. Bacterial strains and culture conditions
90
In the present study one hundred seventy-seven (177) wild strains of Lactobacillus spp., belonging
91
to the DiGeSA microbial collection, previously isolated during the manufacture of artisanal Sicilian
92
cheeses, were investigated for probiotic in vitro characteristics. All strains, including the L.
93
rhamnosus ATCC 53103 (strain GG), used as control, were anaerobically grown using Anaerogen
94
kit (Oxoid, Milan, Italy) at 37° C in MRS medium (Oxoid) plus cycloheximide (Fluka) (100 mg/l).
95
The type strains Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538, Listeria
96
monocytogenes DSM 12464, E. coli 555 (gently provided by Prof. F. Gardini from the University of
97
Bologna, Italy) were routinely cultured on Tryptone Soya Broth (Oxoid) at 37° C under aerobic
98
conditions. Lactobacillus casei DSMZ 20011, Lactobacillus paracasei DSMZ 5622, Lactobacillus
99
plantarum DSMZ 20174, Lactobacillus acidophilus DRU (gently provided by Dr J. Reinheimer
100
from INLAIN, UNL-CONICET, Santa Fe, Argentina) and Enterococcus faecalis CCR300, from
101
DiGeSA collection (University of Catania, Italy) were cultured on MRS medium at 37° C under
102
anaerobic conditions. Strains were maintained at -80° C in the presence of glycerol 20% (v/v), as
103
cryoprotective agent. For inocula preparation, individual colonies of 24 h-old cultures, were
104
resuspended in phosphate buffered saline (PBS) solution (80 mM Na2HPO4, 20 mM NaH2PO4, 100
AC C
EP
TE D
89
4
ACCEPTED MANUSCRIPT 105
mM NaCl, pH 7.5). Cell suspensions were diluted until a final cell density of 108 cfu/ml by
106
measuring the optical density at 600 nm. When necessary, a final density of 109 cfu/ml was used.
107 2.2 Acidic resistance and bile salt tolerance
109
Acidic resistance was examined in MRS broth added of hydrochloric acid (1 M), to obtain a final
110
pH value of 2.5. Strains, grown in MRS broth at 37° C overnight, were inoculated (cell density of
111
108 cfu/ml) into acidified MRS broth. The cell survival was monitored up to 6 h, at different
112
intervals. The survival rates were determined as number of viable cells enumerated on MRS agar,
113
incubated under anaerobic conditions at 37° C for 48 h. Moreover, the optical density (OD) of cell
114
growth into acidified MRS broth was evaluated at 600 nm using Microplate Manager software
115
(Version 5.2.1, Biorad, Milan, Italy).
116
One hundred and five strains, selected on the basis of their resistance to low pH, were evaluated for
117
bile salt tolerance in MRS broth containing a standardized bile extract consisting mainly of sodium
118
glycocholate (Oxoid) and sodium taurocholate (Oxoid) at different concentrations (0.4 %, 1.0 %
119
and 2.0 %, w/v). The strains were inoculated into the medium at cell density of 108 cfu/ml and
120
anaerobically incubated at 37° C up to 6 h. The survival rates were determined as described above.
121
Strains inoculated onto MRS without addition of bile salts were used as control.
SC
M AN U
TE D
EP
122
RI PT
108
2.3. Molecular identification lactobacilli strains
124
Thirteen strains, selected for the characteristics described above, were subjected to genetic
125
identification throughout multiplex-PCR, using species-specific primers targeting a conserved
126
region of the tuf gene. DNA was extracted as previously described (Coudeyras et al., 2008) and
127
PCR amplification was conducted as reported by Ventura and co-workers (2003).
AC C
123
128 129
2.4. Transit tolerance in simulated upper gastrointestinal (GI) tract
5
ACCEPTED MANUSCRIPT Transit tolerance in the simulated upper human gastrointestinal (GI) tract was assessed using an in
131
vitro model by adding gastric and pancreatic juices, as reported by Charteris et al. (1998), with
132
slight modifications. Simulated gastric juice (SGJ) was prepared by dissolving pepsin from porcine
133
gastric mucosa in 0.5% w/v sterile saline to a final concentration of 2 g/l and adjusting the pH to
134
2.5. Simulated small intestinal juice (SSIJ) was prepared by dissolving pancreatin from porcine
135
pancreas, 250 mg/l, and porcine bile extract, 0.45%, in 0.5% w/v sterile saline and adjusting the pH
136
to 7.5. All chemicals were obtained from Sigma Aldrich (St. Louis, MO). The solutions were
137
prepared fresh the same day as the experiment. Bacterial tolerance to SGJ and to SSIJ were tested
138
by mixing 15 µl of bacterial suspension with 1000 µl of gastric or small intestinal juice and 485 µl
139
of 0.5% w/v sterile saline, obtaining a bacterial cell density around 109 cfu/ml. The average final pH
140
of the simulated mixtures was 2.62 and 7.46 for the pH 2.5 and pH 7.5 for SGJ and for SSIJ,
141
respectively. The mixture was vortexed at maximum settings for 10 s and incubated at 37° C. For
142
testing gastric tolerance, 100 µl was removed after 90 and after 120 min for determination of viable
143
counts. Tolerance to SSIJ was determined by removing 100 µl after 120 and after 240 min. To
144
determine the number of viable counts, serial dilutions were placed on MRS agar and aerobically
145
incubated at 30° or 37° C for 48 h before enumeration of colony forming units. The number of
146
colony forming units was expressed as log values, and tolerance over time was compared for the
147
investigated strains.
SC
M AN U
TE D
EP
AC C
148
RI PT
130
149
2. 5. Bacterial adhesion capacity
150
All the thirteen selected strains were examined for the ability to adhere to human colon carcinoma
151
(Caco-2) cells. Caco-2 cell line was purchased from the European Collection of Cell Cultures
152
(ECACC). The cells were cultured in Dulbecco’s modified Eagle’s minimal essential medium
153
(DMEM; HyClone Laboratories Inc., Logan, UT, USA) supplemented with 10% (v/v) of heat
154
inactivated fetal calf serum (Sigma), 1 x non-essential amino acid solution (Sigma Aldrich, Milan
155
Italy), 100 U/ml penicillin and 100 mg/ml streptomycin (Sigma) at 37° C and 5% of CO2. For 6
ACCEPTED MANUSCRIPT adhesion assays, monolayers of Caco-2 cells were prepared on glass cover slips in 24- well tissue-
157
culture plates (Corning, Costar, Sigma). Cells were seeded at a cell density of 5x105 cells per cm2
158
and grown to confluence. The monolayers were maintained for 2 weeks prior to use in adhesion
159
assays. The cell culture medium was changed every day and replaced by fresh non supplemented
160
DMEM at least 1 h before the adhesion assay. The adherence of bacterial strains to Caco-2 cell
161
cultures was investigated by adding 1 ml of bacterial suspension (in DMEM, containing 107 cfu/ml)
162
to wells containing Caco-2 monolayer. After incubation at 37° C for 3 h, the Caco-2 cell cultures
163
were washed three times with 1 ml of Hanks buffered saline solution (Sigma) pre-warmed to 37° C,
164
and then treated with 1 ml of 1% Triton X100. Magnetic fleas were added to the wells and the
165
plates were then placed on a magnetic stirrer for 10 min to lyse the Caco-2 cells and to release the
166
adhered bacteria. The adhesion ratio was calculated by count on MRS agar plates. L. rhamnosus
167
ATCC 53103 (strain GG) was used as positive control for both cell line experiments. Each adhesion
168
assay was carried out in triplicate.
TE D
169
M AN U
SC
RI PT
156
2.6. Hydrophobicity, co-aggregation and auto-aggregation activities
171
The cell surface hydrophobicity (H%) of the thirteen selected strains was performed as described by
172
Solieri et al. (2014) and calculated as percentage of decrease (∆Abs x 100) in the absorbance of the
173
aqueous phase after mixing and phase separations (Abst5) relative to that of original suspension
174
(Abst0) as follows:
175
H% = ∆Abs/Abst0 X 100
176
Auto-aggregation (Auto-A%) ability of the thirteen selected strains was performed according to
177
Solieri et al. (2014) and was expressed as percent decrease in the absorbance after 5 h (∆Abs x 100)
178
relative to that of original suspension (Abst0) as follows:
179
Auto-A% = ∆Abs/Abs t0 x 100
180
In the co-aggregation test bacterial suspensions were prepared and calculated as described by
181
Solieri et al., 2014. The pathogen strain used was E. coli 555.
AC C
EP
170
7
ACCEPTED MANUSCRIPT 182 2.7. Antimicrobial activity
184
The antagonism towards various bacterial pathogens and common bacteria present in the GI tract
185
was evaluated according to Argyri et al. (2013). All the thirteen selected strains were tested in
186
duplicate against Escherichia coli ATCC 25922, Staphilococcus aureus ATCC 6538 and Listeria
187
monocytogenes DSM 12464. MRS broth adjusted to pH 6.5 was used as negative control.
RI PT
183
188 2.8. Antibiotic resistance
190
The following 7 antimicrobial agents (Sigma) were used: ampicillin, penicillin G, and vancomycin
191
as inhibitors of cell wall synthesis; kanamycin, chloramphenicol, tetracycline, streptomycin as
192
inhibitors of protein synthesis; and rifampicin as inhibitors of nucleic acid synthesis. All the
193
antibiotic powders were dissolved in appropriate diluents and filter sterilized prior to addition to
194
MRS medium. Serial dilutions of antibiotics, ranging from 0.25 to 256 µg/ml, were prepared, and
195
vancomycin concentrations of 514 and 1028 µg/ml were also tested. MRS broth containing
196
antibiotics at different concentrations was used to prepare each well of a micro-well plate. The
197
inoculum was adjusted to a turbidity equivalent to 0.5 McFarland standard (ca. 105 cfu/ml) and was
198
derived from a broth culture which was incubated at 37° C for 18 h. One ml of fresh culture was
199
used to inoculate each well, incubated anaerobically at 37° C. Minimal inhibitory concentration
200
(MIC) was determined on MRS broth, since it supported the best growth of all bacteria used in this
201
study. The MIC was defined as the lowest concentration of antibiotic giving a complete inhibition
202
of visible growth in comparison to an antibiotic-free control well. At the same time, the optical
203
density (OD) of cell cultures was evaluated using Microplate Manager software (Version 5.2.1,
204
Biorad) at 600 nm. The OD ≤ 0.020 was considered an indicator of transparency.
AC C
EP
TE D
M AN U
SC
189
205 206
2.9. Haemolytic and bile salt hydrolase activities
8
ACCEPTED MANUSCRIPT The selected strains (13) were tested for haemolytic activity following protocol proposed by Argyri
208
et al. (2013). Bile salt hydrolase (BSH) activity was performed using MRS agar plates
209
supplemented with 0.5% (w/v) of taurodeoxycholic acid (TDCA, Sigma). Overnight MRS broth
210
cultures (15 µl) were inoculated onto the agar medium, which was then incubated anaerobically for
211
48 h at 37° C. BSH activity was present when taurodeoxycholic acid precipitated in the agar
212
medium below and around a colony. The strain L. acidophilus DRU was used as positive control.
RI PT
207
213 2.10. Statistical analysis
215
Results are expressed as the mean and standard deviation error mean (SEM) of three independent
216
experiments with duplicate determinations. Differences were considered statistically significant at
217
p< 0.05. In order to correlate the origin of the 177 strains with their ability to resist to low pH and to
218
tolerate different bile salt concentrations, data obtained were subjected to principal component
219
analysis (PCA) using the statistical software Statistica for Windows (Statistica 6.0 per Windows
220
1998, StatSoft, Vigonza, Italia).
TE D
221
M AN U
SC
214
3. Results
223
The lactobacilli strains
224
3.1. Acidic resistance and bile salt tolerance
225
In the present study tolerance to pH 2.5 and to bile salts were chosen as criteria to select strains to
226
be included in the further experiments. Results are reported in Table 1. Among the 177 lactobacilli
227
investigated, sixteen strains did not survive at pH 2.5 and a total of 161 strains were able to survive
228
after 2 h at pH 2.5 and 105 strains also after 4 h.
229
In detail, 95 and 46 strains maintained the value of about 7-8 log cfu/ml after 4 and 6 h of
230
incubation, respectively, as well as the commercial LGG strain; 9 strains decreased of 2 log cfu/ml
231
after 6 h.
AC C
EP
222
9
ACCEPTED MANUSCRIPT Overall, bile salts at concentration differently affected the survival of the tested strains. Among the
233
105 strains selected for their good resistance to low pH, 48 strains exhibited fairly good bile
234
tolerance after 6 h of incubation, maintaining their concentration higher than 6 log cfu/ml after
235
exposure to 0.4%, while 39 strains were strongly affected by bile salt presence. Only 4 strains were
236
able to maintain the value of 8 log cfu/ml after 6 h of exposure to 2.0% bile.
237
The data obtained after acidic or bile stress of each strain were subjected to principal component
238
analysis (PCA) using a covariance matrix. Only strains showing resistance at least at 0.4% of bile
239
salt for 2 h at 37° C were showed. Avoiding speculation, no statistical correlation (P>0.05) was
240
found between the origin of the strains and the acidic or bile resistance (data not shown). Fig. 1
241
shows the distribution of the strains based on acidic and bile resistance. The first two principal
242
components explained ca. 88.19% of the total variance. The strains FS10, PS11, FS2 PM8, CM1,
243
MF5 and GG were characterized by the highest stress resistance and were located in different zones
244
of the plane delimited by the two principal components. All these strains together with other seven
245
strains (SF6, FM13, FM22, SP13, PS2, FM14 and CM2), showing final cell density higher than 6
246
log after acidic and bile stresses, were selected for further analyses.
247
3.2. Molecular identification of lactobacilli strains
248
The thirteen strains, all isolated from Pecorino Siciliano cheese, were selected on the basis of the
249
properties described above, and were indentified through multiplex analysis, using tuf gene PCR-
250
based assay. Primers used allowed species-specific identification of closely related species, such as
251
Lactobacillus casei group. Results demonstrated that the strains FS2, FS10, PS2, SP13, PS11, SF6,
252
FM13, FM14, FM22 belong to L. rhamnosus species, generating only one amplicon of 520 bp,
253
while the strains CM1, CM2, MF5 and PM8 were ascribed to the Lactobacillus paracasei species,
254
which generated two amplicons (240 and 520 bp) (Supplementary Fig. S1). The origin of the 13
255
selected strains and their species affiliation are reported in Table 2.
AC C
EP
TE D
M AN U
SC
RI PT
232
256 257 10
ACCEPTED MANUSCRIPT 3.3. Transit tolerance in simulated upper gastrointestinal (GI) tract
259
The same thirteen lactobacilli strains, which exhibited the highest acidic and bile resistance, were
260
selected for the in vitro transit tolerance in the GI tract. L. rhamnosus GG was used as positive
261
control (Table 3). Except for the FS10 strain, all tested strains showed a decrease of cell viability
262
during the treatment at pH 2.4. However, the loss of viability ranged from less than 1 log (FS2,
263
PM8 and GG strains) to more than 4 log (CM2, FM13, FM14, FM22, PS2, SF6 and SP13 strains).
264
The viability of the strains CM1, FS2, FS10, PM8 and PS11 was not affected by the exposure to the
265
small intestinal juice with pancreatin and bile salt (Table 3). A good survival rate was found for
266
MF5 and GG strains.
267
M AN U
SC
RI PT
258
3.4. Bacterial adhesion capacity
269
In the present study the adhesion to Caco2 intestinal cells was determined for the thirteen tested
270
lactobacilli strains and results are illustrated in Fig. 2. Cell adhesion capacity to Caco2 is calculated
271
as the percentage of adhering bacteria in relation with the number of bacteria initially present in the
272
well. The adhesion capacity of the 13 strains was highly variable (from 58% to 95%), depending on
273
the bacterial strain. The highest adherence capacity (more than 90%) was demonstrated from strains
274
CM1, MF5, PM8, and GG while adhesion ability ranging from 90 to 70% was revealed by the
275
strain CM2, FM13, FM22, FS10 and FS2. The strains FM14, PS2, SF6 and SP13 showed adhesion
276
ability between 70% and 50%).
EP
AC C
277
TE D
268
278
3.5. Hydrophobicity, co-aggregation and auto-aggregation activities
279
Cell surface hydrophobicity was evaluated by the partitioning ratio of cells between aqueous and
280
aromatic (xylene) layers and was measured in a two-phase system. Results are illustrated in the Fig.
281
3. The cell adherence of the thirteen selected strains ranged from 8 to 93%. Four strains (FS10,
282
MF5, PM8 and PS11) as well as the L. rhamnosus GG, exhibited good hydrophobic cell surface,
283
with a percentage higher than 70%. CM1, CM2, FM13, FM14, FS2 and SF6 showed 11
ACCEPTED MANUSCRIPT hydrophobicity ranging from 65 to 25%, while the strains FM22, PS2 and SP13, belonging to L.
285
rhamnosus species had the most hydrophilic characteristics (Fig. 3).
286
Results of co-aggregation ability of the thirteen selected strains with the pathogen E. coli 555 is
287
illustrated in Fig. 3. Out of 13 strains, 5 (CM1, FS10, MF5, PM8, and PS11) showed high
288
percentage of co-aggregation ranging from 47 to 65%, after incubation at room temperature for 5 h.
289
The highest percentages were displayed by the L. rhamnosus FS10 and by the L. paracasei PM8.
290
Only the strains FM22 and SP13 showed weak co-aggregation properties (no higher than 5%) with
291
E. coli 555.
292
In this study the calculated value of auto-aggregation, revealed a variable distribution with
293
percentage ranging from 5 to 68% (Fig. 3). Compared to GG, only L. rhamnosus FS10 strain
294
displayed similar auto-aggregation value (68%). Five strains (CM1, FS2, MF5, PM8, and PS11)
295
showed good auto-aggregation percentage (more than 40%), whereas the lowest values were found
296
for CM2, FM13, FM14, PS2, SF6, and SP13.
M AN U
SC
RI PT
284
TE D
297 3.6. Antimicrobial activity
299
The inhibitory abilities of the lactobacilli strains, considered in the present study, in the form of cell
300
free spent broth against commensal bacteria of GI tract and against common food pathogens, are
301
shown in Table 4. The strains were also tested against L. casei, L. paracasei and L. plantarum, as
302
philogenetically related species. None of the 13 selected strains, as well as the L. rhamnosus GG,
303
inhibited the growth of the related strains (data not shown), while variability was revealed among
304
strains against pathogens and commensal bacteria of GI tract. In particular, all strains indicated
305
forceful antimicrobial activity against E. coli (with an inhibition zone higher than 8.0 mm in
306
diameter) as L. rhamnosus GG, and variable activity versus L. monocytogenes and E. faecalis
307
strains (Table 4). While 5 lactobacilli strains (FS2, FM13, FM4, FM22, and MF5) partially
308
inhibited (2.0-4.0 mm) the growth of L. monocytogenes and E. faecalis, the other strains exhibited
309
an inhibition zone between 5.0 and 8.0 mm of diameter.
AC C
EP
298
12
ACCEPTED MANUSCRIPT 310 3.7. Antibiotic resistance
312
In table 4 are shown the MIC values of the 13 selected strains to antibiotics. Strains were considered
313
resistant when they showed MIC value higher that the MIC breakpoints established by the European
314
Food Safety Authority (EFSA, 2008). None of the strains exhibited resistance to penicillin G and
315
rifampicin. On the contrary, all tested strains were resistant to vancomycin (without a specific
316
breakpoint from EFSA). Regarding the antibiotics ampicillin, streptomycin and kanamycin, 5
317
strains were resistant to ampicillin, 6 strains to streptomycin, and 6 strains to kanamycin as GG.
318
Most of the strains, as well as GG, revealed the sensitive to tetracycline and to chloramphenicol.
SC
RI PT
311
M AN U
319
3.8. Haemolytic and bile salt hydrolase activities
321
None of the examined strains exhibited β-haemolytic activity when grown in Columbia horse blood
322
agar; only the strains CM1 and CM2 exhibited α-haemolysis (data not shown). The absence of
323
haemolytic activity is considered as a safety prerequisite for the selection of a probiotic strain
324
(FAO/WHO, 2002).
325
Results of bile salt hydrolase (BSH) activity of lactobacilli strains are reported in Table 4. All the
326
strains, excepted the strain MF5, did not exhibit BSH activity, as the GG in TDCA-MRS agar.
EP
AC C
327 328
TE D
320
329
Discussion
330
Among fermented dairy products, traditional cheeses represent an alternative and readily source of
331
lactobacilli with promising functional properties, which could be impact positively on human
332
health. Recently, Solieri and co-workers (2014) demonstrated that Parmigiano Reggiano cheese is
333
an interesting source of potential probiotic non-starter lactobacilli, as well Hashemi and co-workers
334
(2014) revealed the potential functional features of isolates from Kudish cheese, a traditional raw
335
goat cheese from Iran. In the present study, 177 lactobacilli isolated from traditional Sicilian 13
ACCEPTED MANUSCRIPT cheeses were screened for potential probiotic use. It’s noteworthy that the resistance to gastric
337
acidity and to bile salts, the antimicrobial activity, cell surface adhesion, and antibiotic
338
susceptibility are considered fundamental properties for selection of novel probiotic candidates. The
339
initial pH of the stomach and its decrease during gastric digestion significantly affect probiotic
340
strains viability. In this contest, the exposure to pH 2.5 is considered a discriminating factor for
341
selecting very-acidic tolerant strains even if never are directly exposed to gastric fluid (Prosad et al.,
342
1998). Our results revealed a wide range of heterogeneity among tested strains in relation to low pH
343
resistance, and most of the strains exhibited survival to pH 2.5, as previously reported
344
(Xanthopoulos et al., 2000; Mathara et al., 2008).
345
The presence of bile salts and pancreatic enzymes constitute another barrier to the survival of the
346
ingested bacteria during digestion. In the present study, out of 105 tested strains, 48 were resistance
347
to bile salts after 2 h of exposure at all tested percentages. The results are in agreement with those
348
acquired from previous studies, where L. rhamnosus and L. paracasei strains exhibited high in vitro
349
tolerance to bile salts. Moreover, our data revealed high ability of the L. rhamnosus GG to tolerate
350
both high acidity and bile salts, in contrast to results reported by Goldin et al. (1992). Bile tolerance
351
by probiotic has been revealed to be dependent on bile type and on the strain, with tolerance levels
352
of bile salts ranging from 0.125 to 2.0% (Lion et al., 2005). Among the 13 selected strains from
353
Pecorino cheese, which survived under the simulated in vitro static GI conditions, results
354
demonstrate that the low value of pH in the gastric compartment has more influence on the strains
355
survival than the presence of bile and pancreatic juice in duodenum compartment. This findings are
356
in accordance to previous studies (Succi et al., 2005; Vinderola et al., 2009; Pitino et al., 2010;
357
Solieri et al., 2014) and confirmed that the resistance to low pH and bile salts is a strain specific
358
trait (Papamanoli et al., 2003; Pitino et al., 2012). In the human gut, food matrix certainly protect
359
the bacteria from the deleterious effect of gastric and small intestinal secretions (Pitino et al., 2012),
360
improving the viability of microorganisms during gastric transit (Huang and Adams, 2004; Pitino et
361
al., 2012).
AC C
EP
TE D
M AN U
SC
RI PT
336
14
ACCEPTED MANUSCRIPT Up to now is not yet completely clear if bile salt hydrolase (BSH) activity is a desirable trait for
363
promising probiotic strains selection. Current data suggest that this activity could maximize the
364
intestinal survival and persistence of probiotic strains increasing the overall beneficial effects
365
associated with the strain (Begley et al., 2006). Several f bile salt hydrolase enzymes have been
366
characterized and correlated to cholesterol lowering (Liong and Shah, 2005). . Moreover, Our
367
results indicated that all tested strains, except the L. paracasei MF5, were not able to deconjugate
368
bile salts and thus the majority of the breakdown products of the dehydroxylating activity by strains
369
may be precipitated and excreted in feces (Veysey et al., 2001). Moreover, the strains which did not
370
exhibit BSH activity were able to survive at different bile salts concentrations, confirming that the
371
two activities are not correlated each other, in accordance with previous reported data (Moser and
372
Savage, 2001).
373
The ability of the strains to adhere mucosal surface is another commonly encountered criterion for
374
probiotic strains selection, since it is directly related to their colonization and persistence in the GI
375
tract (Morelli, 2007). . Probiotic bacteria compete with invading pathogens for binding site to
376
epithelial cells and the overlying mucus layer in a strain-specific manner (Morrow et al., 2012). Our
377
results for bacterial adherence capacity to Caco-2 cells revealed adhesion ability of the 13 selected
378
strains, confirming that this property for Lactobacillus are strain and matrix dependent (Tallon et
379
al., 2007; Laparra and Sanz, 2009). Moreover, data demonstrated the high adhesion to cells of L.
380
rhamnosus GG strain, in contrast to previous study (Jensen et al., 2012). It is interesting to note that
381
the adhesion ability of lactobacilli has been correlated to cells hydrophobicity, which represents a
382
benefit for bacterial maintenance in the gastrointestinal tract (Kos et al., 2003). This work revealed
383
that strains with high adhesion capacity and hydrofobicity, including L. rhamnosus GG, showed
384
high auto-aggregation and co-aggregation abilities, in accordance with previous data (Pithva et al.,
385
2014). Nevertheless, conflicting evidences have been previously reported (Solieri et al., 2014; Botta
386
et al., 2014), indicating that adhesive and aggregative properties are strain dependent as well as
387
hydrophobic trait. Aggregation and co-aggregation for instance with pathogens, are important
AC C
EP
TE D
M AN U
SC
RI PT
362
15
ACCEPTED MANUSCRIPT properties of probiotic strains in term of colonization, long-term persistence and anti-infection
389
mechanism against pathogen species in the GI tract. Data obtained through in vitro assay are
390
difficult to extrapolate to the situation in the human GI tract, where the host defense systems,
391
competition with the resident microbiota, mucosal shedding, and peristaltic flow are likely to
392
modify the bacterial adhesion (Lebeer et al., 2008). However, in vitro experiments provide
393
important information regarding species and strain differences (Jensen et al., 2012).
394
The ability to produce antimicrobial compounds may be one of the key characteristics for
395
competitive exclusion of pathogen survival in the intestine and expression of a probiotic effect for
396
the host (Salminen et al., 1998; Collado et al., 2005). All 13 selected strains tested showed forceful
397
activity against E. coli, in agreement with previous work (Tulumoglu et al., 2013). However, as
398
previous reported (Ambalam, 2009; Pithva et al., 2014), our results also confirmed the strain-
399
specific nature of the antimicrobial activity, in particular against L. monocytogenes and E. faecalis
400
strains.
401
Evaluating safety aspects, the 13 promising probiotic strains were, therefore, tested for antibiotic
402
resistance and for hemolytic activity. None of the strains exhibited resistance to penicillin G and
403
rifampicin, while all tested strains were resistant to vancomycin, supporting the native resistance of
404
L. casei, L. paracasei, and L. rhamnosus species to this antibiotic (Liu et al., 2009), which is not
405
transferable to other species because it is chromosomally encoded (Morrow et al., 2012). The
406
verification of transferable resistance is recommended prior to consider them safe for human
407
consumption (Reid et al., 2002; Huys et al., 2008). The resistance to vancomycin has been
408
attributed to the presence of D-Ala-D-lactate in their peptidoglycan instead of the normal D-Ala-D-
409
Ala, which is the target of the antibiotic (Monteagudo-Mera et al., 2011). Most of the strains, as the
410
GG strain, revealed the sensitive to tetracycline and chloramphenicol, confirming the generally
411
lower resistance of the lactobacilli species towards these antibiotics (Maragkoudakis et al., 2006)
412
and variable resistance among strains, including the GG, was achieved for the antibiotics ampicillin,
413
streptomycin and kanamycin, in accordance with other previous studies (Kirtzalidou et al. 2011;
AC C
EP
TE D
M AN U
SC
RI PT
388
16
ACCEPTED MANUSCRIPT Argyri et al., 2013; Botta et al., 2014). The resistance to kanamycin has already been reported in
415
several Lactobacillus species and it could be attributable to the absence of cytochrome-mediated
416
electron transport, which mediate drug uptake, and to the membrane impermeability (Elkins et al.,
417
2004). The low resistance to vancomycin, ampicillin, streptomycin and kanamycin, could not
418
represent a safety concern, since they exhibited high susceptibility to clinically relevant antibiotics
419
and for their QPS status (EFSA, 2012) they could be totally free of transferable antibiotic resistance
420
genes. Moreover, the safety properties of the promising probiotic strains were also confirmed by the
421
absence of β-haemolytic α-haemolysis and activity, which was revealed only in two L. paracasei
422
strains, in accordance with Maragkoudakis et al. (2006) and Argyri et al. (2013).
SC
RI PT
414
M AN U
423 Conclusion
425
Traditional cheeses represent an excellent source of lactic acid bacteria biodiversity, which support
426
the selection of promising strains with functional properties.s. Results of the present study reveal
427
that the L. rhamnosus FS10 and L. paracasei PM8 both isolated from Pecorino Siciliano cheese,
428
exhibited in vitro favorable strain-specific probiotic properties higher than the reference
429
rhamnosus GG. Moreover, these strains were confirmed to be safe for the absence of resistance to
430
most clinical antibiotics. Further in vivo investigation will aim to elucidate both their potential
431
health benefits to human and their technological properties before allowing their utilization as
432
probiotics in functional foods.
EP
L.
AC C
433
TE D
424
434
Acknowledgment
435
This work was partially founded by AG Pharma srl, Italy. Authors thank Prof. F. Gardini from the
436
University of Bologna, Italy, and Dr J. Reinheimer from INLAIN, UNL-CONICET, Santa Fe,
437
Argentina for gently providing E coli 555 and L. acidophilus DRU strains, respectively.
438 17
ACCEPTED MANUSCRIPT References
440
Ambadoyiannis, G., Hatzikamari, M., Litopoulou-Tzanetaki, E., Tzanetakis, N., 2005. Probiotic and
441
technological properties of enterococci isolates from infants and cheese. Food Biotechnology 18,
442
307-325.
RI PT
439
Ambalam, P., Prajapati, J.B., Dave, J.M., Nair, B.M., Ljungh, A., Vyas, B.R.M. 2009. Isolation and
444
characterization of antimicrobial proteins produced by a potential probiotic strain of human
445
Lactobacillus rhamnosus 231 and its effect on selected human pathogens and food spoilage
446
organisms. Microbial Ecology in Health and Disease 21, 211–220.
SC
443
Argyri, A.A., Zoumpopoulou, G., Karatzas, K.-A.G., Tsakalidou, E., Nychas, G.-J.E., Panagou,
448
E.Z., Tassou, C. 2013. Selection of potential probiotic lactic acid bacteria from fermented olives
449
by in vitro tests. Food Microbiology 33, 282-291.
452 453
Environmental Microbiology 72, 1729–1738.
TE D
451
Begley, M., Hill, C., Gahan, C.G.M. 2006. Bile salt hydrolase activity in probiotics. Applied and
Bergamini, C., Hynes, E., Meinardi, C., Suárez, V., Quiberoni, A., Zalazar, C. 2010. Pategrás cheese as a suitable carrier for six probiotic cultures. Journal Dairy Research 77, 265-72.
EP
450
M AN U
447
Bernardeau, M., Vernoux, J.P., Henri-Dubernet, S., Guéguen, M. 2008. Safety assessment of dairy
455
microorganisms: the Lactobacillus genus. International Journal of Food Microbiology 3, 278-
456
285.
457 458 459 460
AC C
454
Botta, C., Langerholc, T., Cencic, A., Cocolin, L. 2014. In vitro selection and characterization of new probiotic candidates from table olive microbiota. Plos one 9, 1-15. Charteris, W.P., Kelly, P.M., Morelli, L., Collins, J.K. 1998. Antibiotic susceptibility of potentially probiotic Lactobacillus species. Journal of Food Protection 6, 1636–1643.
18
ACCEPTED MANUSCRIPT 461
Chen, T., Yu, W.H., Izard, J., Baranova, O.V., Lakshmanan, A., Dewhirst, F.E. 2010. The human
462
oral microbiome Database: a web accessible resource for investigating oral microbe taxonomic
463
and genomic information. Database. Vol. 2010, Article ID baq013, p 1-10. Collado, M.C., Gueimonde, M., Hernandéz, M., Sanz, Y., Salminen, S. 2005. Adhesion of selected
465
Bifidobacterium strains to human intestinal mucus and the role of adhesion in enterophatogen
466
exclusion. Journal of Food Protection 68, 2672–2678.
468
Collado, C., Surono, I., Meriluoto, J., Salminen, S. 2007. Indigenous Dadih lactic acid bacteria:
SC
467
RI PT
464
cell-surface properties and interactions with pathogens. Journal of Food Science 72, 89–93. Coudeyras, S., Marchandin, H., Fajon, C., Forestier, C. 2008. Taxonomic and strain-specific
470
identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei
471
group. Applied and Environmental Microbiology 74, 2679–2689.
M AN U
469
Elkins, C.A., Mullis, L.B. 2004. Bile-mediated aminoglycoside sensitivity in Lactobacillus species
473
likely results from increased membrane permeability attributable to cholic acid. Applied and
474
Environmental Microbiology 70, 7200–7209.
TE D
472
European Food Safety Authority (EFSA) 2012. Scientific opinion of the panel on additives and
476
products or substances used in animal feed (FEEDAP) on the updating of the criteria used in the
477
assessment of the bacterial resistance to antibiotics of human or veterinary importance. EFSA
478
Journal 10, 2740-2750. Update of the criteria used in the assessment of bacterial resistance to
479
antibiotics of human or veterinary importance (Technical guidance). The EFSA Journal 732, 1–
480
15.
481 482
AC C
EP
475
FAO/WHO
(2002)
Guidelines
for
the
evaluation
of
probiotics
in
food.
http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/ pp. 1–11.
19
ACCEPTED MANUSCRIPT 483
Hashemi, S.M.B., Shahidi, F., Mortazavi, S.A., Milani, E., Eshaghi, Z. 2014. Potentially probiotic
484
Lactobacillus strains from traditional Kurdish Cheese. Probiotics and Antimicrobial Proteins 6,
485
22–31. Huang, Y., Adams, M.C, 2004. In vitro assessment of the upper gastrointestinal tolerance of
487
potential probiotic dairy propionibacteria. International Journal of Food Microbiology 91, 253–
488
260.
RI PT
486
Huys, G., D’Haene, K., Danielsen, M., Mättö, J., Egervärn, M., Vandamme, P. 2008. Phenotypic
490
and molecular assessment of antimicrobial resistance in Lactobacillus paracasei strains of food
491
origin. Journal of Food Protection 71, 339-344.
M AN U
SC
489
492
Jensen, H., Grimmer, S., Naterstad, K., Axelsson, L. 2012. In vitro testing of commercial and
493
potential probiotic lactic acid bacteria. International Journal of Food Microbiology 153, 216-222.
494
Kirtzalidou, E., Pramateftaki, P., Kotsou, M., Kyriacou, A. 2011. Screening for lactobacilli with probiotic properties in the infant gut microbiota. Anaerobe 30, 1-4.
TE D
495
Kos, B., Suskovic, J., Vukovic, S., Simpraga, M., Frece, J., Matosic, S. 2003. Adhesion and
497
aggregation ability of probiotic strain Lactobacillus acidophilus M92. Journal of Applied
498
Microbiology 94, 981–987.
500 501 502 503 504
Laparra, J.M., Sanz, Y. 2009. Comparison of in vitro models to study bacterial adhesion to the
AC C
499
EP
496
intestinal epithelium. Letters in Applied Microbiology 49, 695–701. Lebeer, S., Vanderleyden, J., De Keersmaecker, S.C. 2008. Genes and molecules of lactobacilli supporting probiotic action. Microbiology and Molecular Biology Reviews 72, 728-764. Leroy, F., De Vuyst, L. 2004. Lactic acid bacteria as functional starter cultures for the food fermentation industry. Trends in Food Science and Technology 15, 67-78.
20
ACCEPTED MANUSCRIPT 505
Licitra, G., Ogier, J.C., Parayre, S., Pediliggieri, C., Carnemolla, T.M., Falentin, H., Madec, M.N.,
506
Carpino, S., Lortal, S. 2007. Variability of bacterial biofilms of the "tina" wood vats used in the
507
Ragusano cheese-making process. Applied and Environmental Microbiology 73, 6980-6987.
509
Liong, M.T., Shah, N.P. 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. Journal of Dairy Science 88, 55-66.
RI PT
508
Liu, C., Zhang, Z.Y., Dong, K., Yuan, J.P., Guo, X.K. 2009. Antibiotic resistance of probiotic
511
strains of lactic acid bacteria isolated from marketed foods and drugs. Biomedical and
512
Environmental Science 22, 401-412.
SC
510
Maragkoudakis, P.A., Zoumpopoulou, G., Miaris, C., Kalantzopoulos, G., Pot, B., Tsakalidou, E.
514
2006. Probiotic potential of Lactobacillus strains isolated from dairy products. International
515
Dairy Journal 16, 189-199.
M AN U
513
Mathara, J.M., Schillinger, U., Kutima, P.M., Mbugua, S.K., Guigas, C., Franz, C., Holzapfel, W.H.
517
2008. Functional properties of Lactobacillus plantarum strains isolated from Maasai traditional
518
fermented milk products in Kenya. Current Microbiology 56, 315-321.
TE D
516
Monteagudo-Mera, A., Caro, I., Rodríguez-Aparicio, L.B., Rúa, J., Ferrero, M.A., García-Armesto,
520
M.R. 2011. Characterization of certain bacterial strains for potential use as starter or probiotic
521
cultures in dairy products. Journal of Food Protection 74, 1379-1386.
523 524 525
AC C
522
EP
519
Morelli, L., 2007. In vitro assessment of probiotic bacteria: from survival to functionality. International Dairy Journal 17, 1278-1283. Morrow, L.E., Gogineni, V., Malesker, M.A. 2012. Probiotics in the intensive care unit. Nutrition in Clinical Practice 27, 235-241.
21
ACCEPTED MANUSCRIPT 526
Moser, S.A., Savage, D.C. 2001. Bile salt hydrolase activity and resistance to toxicity of conjugated
527
bile salts are unrelated properties in lactobacilli. Applied and Environmental Microbiology 67,
528
3476–3480. Oberg, C.J., Moyes, L.V., Domek, M.J., Brothersen, C., McMahon, D.J. 2011. Survival of probiotic
530
adjunct cultures in cheese and challenges in their enumeration using selective media. Journal of
531
Dairy Science. 94, 2220–2230.
RI PT
529
Papamanoli, E., Tzanetakis, N., Litopoulou-Tzanetaki, E., Kotzekidou, P. 2003. Characterization of
533
lactic acid bacteria isolated from a Greek dry-fermented sausage in respect to their technological
534
and probiotic properties. Meat Science 65, 859-867.
M AN U
SC
532
Pithva, S., Shekh, S., Dave, J., Vyas, B.R. 2014. Probiotic attributes of autochthonous Lactobacillus
536
rhamnosus strains of human origin. Biotechnology and Applied Biochemistry 173, 259-277.
537
Pitino, I., Randazzo, C.L., Mandalari, G., Lo Curto, A., Faulks, R.M., Le Marc, Y., Bisignano, C.,
538
Caggia, C., Wickham, M.S.J. 2010. Survival of Lactobacillus rhamnosus in the upper gastro-
539
intestinal tract. Food Microbiology 27, 1121-1127.
TE D
535
Pitino, I., Randazzo, C.L., Cross, K.L., Parker, M.L., Bisignano, C., Wickham, M.S.J., Mandalari,
541
G., Caggia, C. 2012. Survival of Lactobacillus rhamnosus strains inoculated in cheese matrix
542
during simulated human digestion. Food Microbiology 31,57-63.
544
AC C
543
EP
540
Prosad, J., Gill, H., Smart, J., Copal, P.K. 1998. Selection and characterization of Lactobacillu and Bifidobacterium strains for use as probiotics. Iternational Dairy Journal 8, 993-1002.
545
Randazzo, C.L., Torriani, S., Akkermans, A.D.L., De Vos, W.M., Vaughan, E.E. 2002. Diversity,
546
dynamics, and activity of bacterial communities during production of an artisanal Sicilian cheese
547
as evaluated by 16S rRNA analysis. Applied and Environmental Microbiology 68, 1882–1892.
22
ACCEPTED MANUSCRIPT 548
Randazzo, C.L., Vaughan, E.E., Caggia, C. 2006. Artisanal and experimental Pecorino Siciliano
549
cheese: microbial dynamics during manufacture by culturing and PCR-DGGE analyses.
550
International Journal of Food Microbiology 109, 1–8. Reid, G., Araya, M., Morelli, L., Sanders, M.E., Stanton, C., Pineiro, M., Ben Embarek, P. 2002.
552
Guidelines for the evaluation of probiotics in food: Report of a joint FAO/WHO working group
553
on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada, 30
554
April to 1 May.
SC
556
Saarela, M., Mogensen, G., Fonden, R., Matto, J., Mattila-Sandholm, T. 2000. Probiotic bacteria: safety, functional and technological properties. Journal of Biotechnology 84, 197–215.
M AN U
555
RI PT
551
Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fondén, R.,
558
Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E., Mattila-Sandholm, T. 1998.
559
Demonstration of safety of probiotics- a review. International Journal of Food Microbiology 44,
560
93–106.
TE D
557
Solieri, L., Bianchi, A., Mottolese, G., Lemmetti, F., Giudici, P. 2014. Tailoring the probiotic
562
potential of non-starter Lactobacillus strains from ripened Parmigiano Reggiano cheese by
563
in vitro screening and principal component analysis. Food Microbiology 38, 240-249.
EP
561
Succi, M., Tremonte, P., Reale, A., Sorrentino, E., Grazia, L., Pacifico, S., Coppola, R. 2005. Bile
565
salt and acid tolerance of Lactobacillus rhamnosus strains isolated from Parmigiano Reggiano
566
cheese. FEMS. 244, 129–137.
AC C
564
567
Tallon, R., Arias, S., Bressollier, P., Urdaci, M.C. 2007. Strain- and matrix-dependent adhesion of
568
Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. Journal of Applied
569
Microbiology 102, 442–451.
23
ACCEPTED MANUSCRIPT
571 572 573
Tulumoglu, S., Yuksekdag, Z.N., Beyatli, Y., Simsek, O., Cinar B, Yaşar E. 2013. Probiotic properties of lactobacilli species isolated from children's feces. Anaerobe 24, 36-42. Van Baarlen, P., Wells, J.M., Kleerebezem, M. 2013 Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends in Immunology 34, 208-215.
RI PT
570
Ventura, M., Canchaya, C., Meylan, V., Klaenhammer, T.R., Zink, R. 2003. Analysis,
575
characterization, and loci of the tuf genes in Lactobacillus and Bifidobacterium species and their
576
direct application for species identification. Applied and Environmental Microbiology 69, 6908-
577
6922.
579
Veysey, M.J., Thomas, L.A., Mallet, A.I., Jenkins, P.J., Besser, G.M., Murphy, G.M., Dowling,
M AN U
578
SC
574
R.H. 2001. Colonic transit influences deoxycholic acid kinetics. Gastroenterology 121, 812-822. Vinderola, C.G., Prosello, W., Molinari, F., Ghiberto, D., Reinheimer, J.A. 2009. Growth of
581
Lactobacillus paracasei A13 in Argentinean probiotic cheese and its impact on the
582
characteristics of the product. International Journal of Food Microbiology 135, 171-174.
TE D
580
Walter, J. 2008. Ecological role of Lactobacilli in the gastrointestinal tract: Implications for
584
fundamental and biomedical research. Applied and Environmental Microbiology 74, 4985–4996.
585
Xanthopoulos, V., Litopoulou-Tzanetaki, E., Tzanetakis, N. 2000. Characterization of Lactobacillus
AC C
586
EP
583
isolates from infant faeces as dietary adjuncts. Food Microbiology 17, 205-215.
24
ACCEPTED MANUSCRIPT Table and Figure legend Table 1 Resistance to low pH and tolerance at different bile salt concentrations of Lactobacillus spp. strains.
RI PT
Table 2
Origin of selected strains and species affiliation through tuf gene PCR-based assay.
Table 3
SC
Transit tolerance in simulated upper gastrointestinal (GI) tract expressed as viability of lactobacilli.
M AN U
Table 4
Antimicrobial activity of cell free spent broth of lactobacilli strains against common pathogens, antibiotic resistance and bile salt hydrolase activity of the strains.
Figure 1
TE D
Survival of lactobacilli strains in relation to resistance at pH 2.5 and to tolerance at 1% of bile salts. In the x-and y-axes the OD values of each strain grown onto MRS medium after 4 h of incubation at 37°C at 1% of bile salt and at pH 2.5, respectively, are reported. Figure 2
AC C
Figure 3
EP
Adhesion ability to the Caco 2 cell lines of the 13 selected lactobacilli strains and LGG strain. The capacity is calculated as the percentage of adhered lactobacilli in relation to the total number of strains added (log 8+0.3). (Error bars indicate standard deviation from two replications).
Hydrophobicity, auto-aggregation and co-aggregation with E. coli percentage of lactobacilli strains. (Error bars indicate standard deviation from two replication). Figure S1
Profile of multiplex- PCR using tuf gene of the thirteen selected strains. M: 1kb plus marker; lines 1, 5, 6 and 10: strains identified as L. paracasei species (bands at 540 bp and 240 bp) and lines 2, 3, 4, 7, 8, 9, 11, 12, and 13: strains identified as L. rhamnosus species (band at 540 bp).
ACCEPTED MANUSCRIPT Table 2 Origin of selected strains and species affiliation through tuf gene PCR-based assay Strains
Origin
Species affiliation
PM8
Pecorino cheese 60 days old
L. paracasei
Pecorino cheese 120 days old L. paracasei
CM1, CM2
Pecorino cheese 180 days old L. paracasei
AC C
EP
TE D
M AN U
SC
MF5
RI PT
PS11, SP13, PS2 Pecorino cheese 60 days old L. rhamnosus SF6, FM13, FM14, Pecorino cheese 120 days old L. rhamnosus FM22, FS10, FS2
ACCEPTED MANUSCRIPT
Table 1 Resistance to low pH and tolerance at different bile salt concentrations of Lactobacillus spp. strains Strainsa 2h
RI PT
CS1, PM1, PM2, PM3, PM5, PM6, PM9, PM13, PM18, PM19, PM20, PM24, PM25, PM26, MP1, MP2, MP3, MP4, MP8, MP9, MP10, MP11, MP12, MP14, MP16, MP17, MP19, MP20, MP21, MP22, MP24, MP15, FM12 CS2, CS3, SP16, SP17, SP18, SP15, SP19, SP21, MC1, PM16, FM2, FM6, FM8, FM9, FM20, FM21
SC1, SF1, SF2, SF3, SF4, SF5, SF7, SF8, SF9, SF10, SF11, SF13, SF14, SF15, SF16, SF17, MF4, MF8, MP7,
SC
MP5, MP6, MP13, FM18 PS2, PS1, PS3, PS8, PS9, PS12, PS13, PS15, PS17, SP4,SP11, SP26, SP29 PS4, PS5, PS6, PS7, SP1, SP2, SP6, SP7, SP8, SP9, SP10, SP20, SP22, SP23
M AN U
PS10, PS14, SP4, SP3, SP14, SP28, SP24, FS18, PM4, PM7, PM10, PM11, PM12, PM14, PM15, PM17, PM21, PM22, PM23, PM27, PM28, MP18, MP23, FM1, FM3, FM4, FM5, FM7, FM10, FM11, FM16, FM19 PS11, FS10, FS14, FS15, FS19 PS16 PS18, PS19, FS1 SP13
CM1
-
ND
ND
ND
-
-
-
ND
ND
ND
+
-
-
ND
ND
ND
+++
+++
++
***
*
*
+++
+++
++
*
-
-
+++
+++
+++
-
-
-
+++
+++
+++
***
**
**
+++
+++
++
-
-
-
+++
+++
+++
*
-
-
+++
++
++
***
-
-
++
+
+
-
-
-
+++
++
+
***
***
***
+
***
***
***
+++
++
***
**
**
SF6, SF12, SF18, SF19
+++
+++
+++
***
*
*
+++
+++
+++
***
**
**
+++
+++
++
***
*
*
+++
++
+
***
**
**
+++
++
++
*
-
-
+++
+++
+++
***
**
*
+++
+++
++
***
***
***
+++
+++
+++
***
**
**
FM17 FM22 MF5, MF7 GG
EP
+++
FM14
c)
-
+++
FM13, FM15
b)
++
+++
PM8
a)
6h
Bile salt tolerance atc: 0.4% 1.0% 2.0%
FS2, FS3, FS4, FS5, FS6, FS7, FS8, FS9, FS11, FS12, FS13, FS16, FS17, FS20, FS21, SF20
AC C
CM2
TE D
SP25, MF1, MF2, MF3, MF6, MF9
pH 2.5b 4h
Strain code +++: range of the final viable counts of 7-8 log cfu/ml; ++: range of the final viable counts of 6-7 log cfu/ml; +: range of the final viable counts of 5-6 log cfu/ml; -: the final viable counts